RedHill Biopharma Ltd.: RedHill gives up migraine product (RHB-103). Upside remains, but the price target is decreased to NIS 2.27.

• jaimeuss_admin
• 17 בSeptember 2018
• Research
• 0 Comments

Continue Reading